文献速递妇科

子宫内膜样卵巢癌的分子谱分析与分子分型

Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
PubMed 文献 · Gynecol Oncol · 2019-07-21

该研究对无同步子宫内膜癌的纯子宫内膜样卵巢癌进行靶向或全基因组测序,并与高级别浆液性卵巢癌、子宫内膜样子宫内膜癌及同步子宫内膜样卵巢癌比较突变频率,发现纯子宫内膜样卵巢癌可分层为四种分子亚型,MSI亚型预后良好,且存在可靶向突变。

要点

  • 纯子宫内膜样卵巢癌常见KRAS、PIK3CA、PTEN、CTNNB1、ARID1A和TP53突变。
  • 纯子宫内膜样卵巢癌可分层为POLE超突变3%、MSI高突变19%、拷贝数高17%和拷贝数低61%四种亚型。
  • MSI高突变亚型均显示良好结局,部分肿瘤携带AKT1和ERBB2热点突变等可靶向突变。

核心结论

  • 子宫内膜样卵巢癌在基因组水平具有异质性,并携带可靶向的遗传改变。
  • 尽管纯子宫内膜样卵巢癌、同步子宫内膜样卵巢癌和子宫内膜样子宫内膜癌的体细胞突变谱相似,但已知驱动基因的突变频率不同。
  • 需要进一步研究以明确分子亚型对子宫内膜样卵巢癌患者结局和治疗的影响。

研究设计与样本

  • 对子宫内膜样卵巢癌及匹配的正常样本进行靶向341-468个癌症相关基因的大规模平行测序(n=8)或全基因组测序(n=28)。
  • 将子宫内膜样卵巢癌的突变频率与来自癌症基因组图谱的高级别浆液性卵巢癌(n=224)和子宫内膜样子宫内膜癌(n=186)以及同步子宫内膜样卵巢癌(n=23)进行比较。

主要发现

  • 子宫内膜样卵巢癌具有异质性,常携带KRAS、PIK3CA、PTEN、CTNNB1、ARID1A和TP53突变。
  • 与高级别浆液性卵巢癌相比,子宫内膜样卵巢癌TP53突变频率较低,而KRAS、PIK3CA、PIK3R1、PTEN和CTNNB1突变频率较高。
  • 与同步子宫内膜样卵巢癌和纯子宫内膜样子宫内膜癌相比,纯子宫内膜样卵巢癌PTEN、PIK3R1和ARID1A突变频率较低。
  • 子宫内膜样卵巢癌可分层为四种分子亚型:POLE超突变型3%、MSI高突变型19%、拷贝数高(浆液样)型17%和拷贝数低(子宫内膜样)型61%。
  • 除微卫星不稳定外,部分子宫内膜样卵巢癌携带潜在可靶向突变,包括AKT1和ERBB2热点突变。

局限性

  • 需要进一步研究以明确分子亚型对子宫内膜样卵巢癌患者结局和治疗的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endometrioid ovarian carcinomas (EOCs) comprise 5-10% of all ovarian cancers and commonly co-occur with synchronous endometrioid endometrial cancer (EEC). We sought to examine the molecular characteristics of pure EOCs in patients without concomitant EEC. METHODS: EOCs and matched normal samples were subjected to massively parallel sequencing targeting 341-468 cancer-related genes (n = 8) or whole-genome sequencing (n = 28). Mutational frequencies of EOCs were compared to those of high-grade serous ovarian cancers (HGSOCs; n = 224) and EECs (n = 186) from The Cancer Genome Atlas, and synchronous EOCs (n = 23). RESULTS: EOCs were heterogeneous, frequently harboring KRAS, PIK3CA, PTEN, CTNNB1, ARID1A and TP53 mutations. EOCs were distinct from HGSOCs at the mutational level, less frequently harboring TP53 but more frequently displaying KRAS, PIK3CA, PIK3R1, PTEN and CTNNB1 mutations. Compared to synchronous EOCs and pure EECs, pure EOCs less frequently harbored PTEN, PIK3R1 and ARID1A mutations. Akin to EECs, EOCs could be stratified into the four molecular subtypes: 3% POLE (ultramutated), 19% MSI (hypermutated), 17% copy-number high (serous-like) and 61% copy-number low (endometrioid). In addition to microsatellite instability, a subset of EOCs harbored potentially targetable mutations, including AKT1 and ERBB2 hotspot mutations. EOCs of MSI (hypermutated) subtype uniformly displayed a good outcome. CONCLUSIONS: EOCs are heterogeneous at the genomic level and harbor targetable genetic alterations. Despite the similarities in the repertoire of somatic mutations between pure EOCs, synchronous EOCs and EECs, the frequencies of mutations affecting known driver genes differ. Further studies are required to define the impact of the molecular subtypes on the outcome and treatment of EOC patients.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Cybulska P, Paula ADC, Tseng J, et al. Molecular profiling and molecular classification of endometrioid ovarian carcinomas. Gynecol Oncol. 2019. PMID: 31340883. doi:10.1016/j.ygyno.2019.07.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。